Manufacturing Cell Therapies Using Engineered Biomaterials

被引:33
作者
Abdeen, Amr A. [1 ]
Saha, Krishanu [1 ,2 ,3 ]
机构
[1] Univ Wisconsin, Wisconsin Inst Discovery, Madison, WI 53706 USA
[2] Univ Wisconsin, Dept Biomed Engn, Madison, WI 53706 USA
[3] Univ Wisconsin, Dept Med Hist & Bioeth, Madison, WI 53706 USA
基金
美国国家科学基金会;
关键词
PLURIPOTENT STEM-CELLS; EXTRACELLULAR-MATRIX; CLINICAL-TRIALS; DECIPHER CELL; CARDIOMYOCYTES; HETEROGENEITY; CHALLENGES; PLATFORM; CULTURE; DESIGN;
D O I
10.1016/j.tibtech.2017.06.008
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Emerging manufacturing processes to generate regenerative advanced therapies can involve extensive genomic and/or epigenomic manipulation of autologous or allogeneic cells. These cell engineering processes need to be carefully controlled and standardized to maximize safety and efficacy in clinical trials. Engineered biomaterials with smart and tunable properties offer an intriguing tool to provide or deliver cues to retain stemness, direct differentiation, promote reprogramming, manipulate the genome, or select functional phenotypes. This review discusses the use of engineered biomaterials to control human cell manufacturing. Future work exploiting engineered biomaterials has the potential to generate manufacturing processes that produce standardized cells with well-defined critical quality attributes appropriate for clinical testing.
引用
收藏
页码:971 / 982
页数:12
相关论文
共 106 条
[11]   Regulating Stem Cell Secretome Using Injectable Hydrogels with In Situ Network Formation [J].
Cai, Lei ;
Dewi, Ruby E. ;
Goldstone, Andrew B. ;
Cohen, Jeffrey E. ;
Steele, Amanda N. ;
Woo, Y. Joseph ;
Heilshorn, Sarah C. .
ADVANCED HEALTHCARE MATERIALS, 2016, 5 (21) :2758-2764
[12]  
Caiazzo M, 2016, NAT MATER, V15, P344, DOI [10.1038/NMAT4536, 10.1038/nmat4536]
[13]   The MSC: An Injury Drugstore [J].
Caplan, Arnold I. ;
Correa, Diego .
CELL STEM CELL, 2011, 9 (01) :11-15
[14]   High-Content Analysis of CRISPR-Cas9 Gene-Edited Human Embryonic Stem Cells [J].
Carlson-Stevermer, Jared ;
Goedland, Madelyn ;
Steyer, Benjamin ;
Movaghar, Arezoo ;
Lou, Meng ;
Kohlenberg, Lucille ;
Prestil, Ryan ;
Saha, Krishanu .
STEM CELL REPORTS, 2016, 6 (01) :109-120
[15]  
Chiappini C, 2015, NAT MATER, V14, P532, DOI [10.1038/NMAT4249, 10.1038/nmat4249]
[16]   Linking Transgene Expression of Engineered Mesenchymal Stem Cells and Angiopoietin-1-induced Differentiation to Target Cancer Angiogenesis [J].
Conrad, Claudius ;
Huesemann, Yves ;
Niess, Hanno ;
von Luettichau, Irene ;
Huss, Ralf ;
Bauer, Christian ;
Jauch, Karl-Walter ;
Klein, Christoph A. ;
Bruns, Christiane ;
Nelson, Peter J. .
ANNALS OF SURGERY, 2011, 253 (03) :566-571
[17]   Mesenchymal stem/stromal cells as a delivery platform in cell and gene therapies [J].
D'souza, Naomi ;
Rossignoli, Filippo ;
Golinelli, Giulia ;
Grisendi, Giulia ;
Spano, Carlotta ;
Candini, Olivia ;
Osturu, Satoru ;
Catani, Fabio ;
Paolucci, Paolo ;
Horwitz, Edwin M. ;
Dominici, Massimo .
BMC MEDICINE, 2015, 13
[18]   Impact of Local versus Global Ligand Density on Cellular Adhesion [J].
Deeg, Janosch A. ;
Louban, Ilia ;
Aydin, Daniel ;
Selhuber-Unkel, Christine ;
Kessler, Horst ;
Spatz, Joachim P. .
NANO LETTERS, 2011, 11 (04) :1469-1476
[19]   Cardiomyocytes from human pluripotent stem cells: From laboratory curiosity to industrial biomedical platform [J].
Denning, Chris ;
Borgdorff, Viola ;
Crutchley, James ;
Firth, Karl S. A. ;
George, Vinoj ;
Kalra, Spandan ;
Kondrashov, Alexander ;
Hoang, Minh Duc ;
Mosqueira, Diogo ;
Patel, Asha ;
Prodanov, Ljupcho ;
Rajamohan, Divya ;
Skarnes, William C. ;
Smith, James G. W. ;
Young, Lorraine E. .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2016, 1863 (07) :1728-1748
[20]   Multiplex Genome Editing As a Platform for "Off-the-Shelf" Adoptive CAR T-Cell Immunotherapies [J].
Derniame, Sophie ;
Zhan, Hong ;
Poirot, Laurent ;
Schiffer-Mannioui, Cecile ;
Galetto, Roman ;
Beurdeley, Marine ;
Reynier, Stephan ;
Arnould, Sylvain ;
Qasim, Waseem ;
Smith, Julianne .
BLOOD, 2014, 124 (21)